10-Year CV Risk Calculator

Four bands, and what each one usually sets off

A score of 0.6% and a score of 35.5% are not the same kind of problem, and the guideline does not treat them as one. The percentage only becomes useful once you know which band it falls in and what that band normally sets off at a visit.

Every band in that table came out of this calculator, so you can rebuild each row by typing the same numbers. The two inputs this page follows most closely are the ones a person can shift inside a year: systolic pressure and the diabetes answer.

One worked example frames the rest of the page. A 58-year-old white woman with total cholesterol 210, HDL 55, untreated systolic 138, no smoking and no diabetes scores 3.2%. Drop her systolic to 120 and the score eases to 2.5%. Mark diabetes and it jumps to 6.2%, nearly double. Two inputs, two moves, one number.

The math runs entirely in this browser tab, and nothing typed here leaves the page.

Blood pressure: what every 10 mm Hg buys or costs

The equation reads the systolic value only, the top number, and it reads it on a log scale, so the price of 10 mm Hg grows with age. The table below holds cholesterol at 200, HDL at 50 and the reading untreated.

Between systolic 120 and 130 the step is 0.7 points at 55. At 70 the same step is 2.2 points. The second thing to notice is that the curve never flattens: at every age in the table, another 10 mm Hg keeps charging, which is why clinics average two or three readings before treating a number.

The worked example shows the same pull from the other side. The 58-year-old woman at systolic 138 scores 3.2%, at 150 she scores 3.8%, and back at 120 she keeps 0.8 points off the board. No other single input on the form moves that far that fast without a prescription pad.

Treated versus untreated: why the same reading scores differently

The equations give a treated systolic reading its own coefficient, and it is the heavier one. For white men the weight is 1.797 treated against 1.764 untreated; the other three sets carry the same arrangement. A 140 that arrives on medication scores higher than a 140 that arrived on its own.

The gap is about a point at every age shown: at 55, a treated 140 scores 7.6% against 6.5% untreated. The reasoning behind the weights is exposure. A reading held at 140 by a pill usually means years of higher pressure before the pill, and the equation prices that history in.

Mark yes only for a prescription that is current. A drug stopped last spring no longer counts, and the untreated column becomes the honest one. This is also why the score can rise after treatment starts even when the reading improves: the flag moved, and the flag is doing real work.

Diabetes: one yes worth several points

Diabetes enters as a switch, not a dial. There is no degree of it in the equation, and the weight it carries makes the answer worth as much as a pack a day at some ages. The table below uses a white man at cholesterol 200, HDL 50, systolic 130.

At 55 the switch is worth about 5.1 points, and the price climbs with age because the rest of the equation is climbing too. A 60-year-old Black man at cholesterol 200, HDL 45, systolic 120 with diabetes scores 13.9%, and the same man at systolic 140 scores 18.0%: the two levers this page tracks stack on top of each other.

The guideline handles diabetes with a shortcut. For adults aged 40 to 75 with diabetes, the 2018 cholesterol guideline suggests a moderate-intensity statin regardless of the calculated score, because diabetes alone carries enough risk to earn the conversation. The score still matters for choosing intensity and for tracking where someone sits inside the band.

Where the statin conversation starts

The score lands in one of four bands, and each band carries a different script. The cut points come from the 2013 guideline and carried over into the 2018 cholesterol guideline that set today's statin advice.

Risk enhancers are the factors the equation cannot see, and they matter most between 5% and 7.5%. Family history of early heart disease, LDL of 160 or higher, chronic kidney disease, metabolic syndrome, inflammatory conditions such as rheumatoid arthritis, triglycerides of 175 or higher, and South Asian ancestry all count. A coronary calcium score of zero can pull a borderline call back toward watchful waiting, while a score above 100 pushes it forward.

Diabetes short-circuits the ladder for many people: at ages 40 to 75 the statin talk usually happens whatever the band says. Blood pressure works the other way, by moving the score itself. Bringing systolic from 150 to 130 at age 55 takes the standard profile from 7.3% down to 5.7%, a cut of 1.6 points, which is often the difference between the borderline and low bands.

Six questions worth asking at the visit

The score is a conversation opener, so it helps to walk in with the questions written down. These six cover most of what the bands are asking for.

1. What is my LDL, and what target goes with my band? High-band patients often get a target below 70.
2. Are my two or three blood pressure readings consistent, or does one arm or one visit change the story?
3. Do any of my risk enhancers, family history, kidney function, triglycerides, move me between bands?
4. Would a coronary calcium score change the plan if my number sits between 5% and 7.5%?
5. If a statin is on the table, what are the muscle and liver checks, and what would make us stop or step down?
6. When do we recheck the panel and the blood pressure average to see if the plan is working?

Bring the calculator output with the inputs filled in. A clinician can spot a wrong entry, an outdated lab, or a reading taken on a rushed morning faster than any formula can.

What the number cannot see

The output is an estimate of hard events only: first heart attack, death from coronary heart disease, or stroke, the same set the CDC tracks. Heart failure, atrial fibrillation and kidney disease progression sit outside it, and someone who already had an event needs different math entirely.

The inputs are a snapshot too. Family history, lipoprotein(a), sleep, and years of exposure never enter, and the two race coefficient sets leave most of the world scored on a model that was not fitted for them. The American Heart Association's 2023 PREVENT equations drop race and add kidney function, though most statin thresholds in daily use still refer to the 2013 tool.

Treat the panel as a way to test one change at a time: what a lower systolic does, what the diabetes switch costs, where the band moves. Then take the honest inputs to a clinician, because a percentage is an argument for a conversation, and the conversation is where the decisions get made.